GE HealthCare Technologies Non-GAAP EPS of $1.31, revenue of $4.93B
GE HealthCare Technologies press release (NASDAQ:GEHC): Q4 Non-GAAP EPS of $1.31.
Revenue of $4.93B (+7.6% Y/Y).
Reaffirms 2023 guidance:
Organic revenue growth in the range of 5% to 7% year-over-year.
Adjusted EBIT margin in the range of 15.0% to 15.5%, reflecting an expansion of 50 to 100 basis points versus 2022 Standalone Adjusted EBIT margin of 14.5%.

Adjusted effective tax rate (ETR) in the range of 23% to 25%.
Free cash flow conversion of 85% or more for the full year. The Company's cash flow outlook assumes that the legislation requiring R&D capitalization for tax purposes is repealed or deferred beyond 2023. The Free cash flow impact of this legislation is approximately 10 points of Free cash flow conversion for the year.
Introduces guidance for Adjusted EPS in the range of $3.60 to $3.75. This compares to 2022 Standalone Adjusted EPS of $3.38.